Le Lézard
Classified in: Health
Subjects: RCL, CFG

Food Recall Warning (Allergen) - Amy's brand Golden Lentil Dal Soup recalled due to undeclared egg protein


Product photos are available at: https://bit.ly/35IOeTt

OTTAWA, Jan. 17, 2021 /CNW/ - Amy's Kitchen Inc. is recalling Amy's brand Golden Lentil Dal Soup from the marketplace because it may contain egg protein which is not declared on the label. People with an allergy to egg should not consume the recalled products described below.

The following product has been sold in British Columbia, Ontario and Quebec and may have been sold in other provinces and territories.

Recalled product

Brand

Product

Size

UPC

Codes

Amy's

Golden Lentil Dal Soup

398 mL

0 42272 90593 5

Best Before
06/2023
Lot: 30F1520

What you should do

Check to see if you have the recalled product in your home. Recalled products should be thrown out or returned to the store where they were purchased.

If you have an allergy to egg, do not consume the recalled product as it may cause a serious or life-threatening reaction.

Background

This recall was triggered by Canadian Food Inspection Agency (CFIA) test results. The CFIA is conducting a food safety investigation, which may lead to the recall of other products. If other high-risk products are recalled, the CFIA will notify the public through updated Food Recall Warnings.

The CFIA is verifying that industry is removing the recalled product from the marketplace.

Reactions

There have been no reported reactions associated with the consumption of this product.

SOURCE Canadian Food Inspection Agency (CFIA)


These press releases may also interest you

at 19:12
CCA Industries, Inc. , announced today its results for the year ended November 30, 2020.  The results can be found on the chart below. Net loss was $127,477 for the year ended November 30, 2020 as compared to net income of $554,462 for the year ended...

at 19:05
Knight Therapeutics Inc. , ("Knight") a pan-American (ex-USA) specialty pharmaceutical company, announced today the Canadian commercial availability of IBSRELA (tenapanor), a first-in-class therapy for the treatment of irritable bowel syndrome with...

at 19:00
The "Regenerative Medicine Market Share, Size, Trends, & Industry Analysis Report, By Therapy; By Products; By Application; By Region: Segment Forecast, 2020-2026" report has been added to ResearchAndMarkets.com's offering. The Regenerative Medicine...

at 18:50
Tianma, a leading global manufacturer of flat panel displays, has introduced a new product family of TFT LCD Modules (Thin Film Transistor - Liquid Crystal Display). The new P-Series (Professional Series) of standard products is dedicated to support...

at 18:30
SQI Diagnostics Inc. , a precision medicine company that discovers, develops and commercializes innovative rapid diagnostic testing for healthcare professionals, patients and consumers worldwide, today reported its financial and operational results...

at 18:15
The "Global Genomics Market by Product & Service (System & Software, Consumables, Services), Technology (Sequencing, PCR), Application (Drug Discovery & Development, Diagnostic, Agriculture), End-user (Hospital & Clinics, Research Centers), and...



News published on 17 january 2021 at 00:40 and distributed by: